The case of Colombian scientist Diego Gomez — on trial for copyright violation for sharing a research paper — is likely to reach a head later this month.

We describe the mathematical foundations and structure of TrueReview, an open-source tool we propose to build in support of post-publication review.

Analysis of scholarly publishing’s ‘Napster’ shows that academics are not prepared to wait to access research. 35 per cent of articles downloaded from Sci-Hub were less than two years old when they were accessed.

The National Institutes of Health (NIH) announced plans last week to impose a new grant scoring system that would cap how much support an investigator can receive from the agency.

Technologist argues that artificial intelligence could make publishing decisions in milliseconds.

Add another high-profile departure to the list of people leaving Verily, the Google-spawned health science company: Thomas Insel, a neuroscientist and former head of the National Institutes of Mental Health who was leading Verily’s mental health initiatives.

Researchers and manufacturers face possible jail time — or execution — for fraudulent submissions to nation's drug agency.

Rise in copyright breaches prompts industry to discuss ways to allow ‘fair sharing’ of articles.

China has a lucrative market for fake research reagents. Some scientists are fighting back.

New York City investor organized discussion to explain biomedical “ecosystem” to Trump officials

An analysis shining light on institutions that have thought outside the box on research collaboration and funding.

At the halfway point of the EU’s biggest research and innovation funding programme, Horizon 2020, we explore a selection of EU-funded projects whose breakthroughs could help to shape Europe during the next 60 years.

A $2 million crowdfunding campaign will finance an ambitious series of studies—designed under the watchful eye of the FDA—into psychedelics as treatment.